Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

279 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The approval of a disease-modifying treatment for Alzheimer's disease: impact and consequences for the nuclear medicine community.
Garibotto V, Albert NL, Barthel H, van Berckel B, Boellaard R, Brendel M, Cecchin D, Ekmekcioglu O, van de Giessen E, Guedj E, Lammerstma AA, Semah F, Traub-Weidinger T, Van Weehaeghe D, Morbelli S; EANM Neuroimaging Committee. Garibotto V, et al. Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3033-3036. doi: 10.1007/s00259-021-05485-y. Eur J Nucl Med Mol Imaging. 2021. PMID: 34272989 No abstract available.
A Cochrane review on brain [¹⁸F]FDG PET in dementia: limitations and future perspectives.
Morbelli S, Garibotto V, Van De Giessen E, Arbizu J, Chételat G, Drezgza A, Hesse S, Lammertsma AA, Law I, Pappata' S, Payoux P, Pagani M; European Association of Nuclear Medicine. Morbelli S, et al. Among authors: garibotto v. Eur J Nucl Med Mol Imaging. 2015 Sep;42(10):1487-91. doi: 10.1007/s00259-015-3098-2. Eur J Nucl Med Mol Imaging. 2015. PMID: 26067090 Review. No abstract available.
The need of standardization and of large clinical studies in an emerging indication of [18F]FDG PET: the autoimmune encephalitis.
Morbelli S, Arbizu J, Booij J, Chen MK, Chetelat G, Cross DJ, Djekidel M, Drzezga A, Ekmekcioglu O, Garibotto V, Hesse S, Ishii K, Jafari L, Lammertsma AA, Law I, Mathews D, Minoshima S, Mosci K, Pagani M, Pappata S, Silverman DH, Signore A, Van De Giessen E, Villemagne V, Barthel H; European Association of Nuclear Medicine (EANM) and of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). Morbelli S, et al. Among authors: garibotto v. Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):353-357. doi: 10.1007/s00259-016-3589-9. Epub 2016 Dec 6. Eur J Nucl Med Mol Imaging. 2017. PMID: 27924371 No abstract available.
Erratum to: The need of standardization and of large clinical studies in an emerging indication of [18 F]FDG PET: the autoimmune encephalitis.
Morbelli S, Arbizu J, Booij J, Chen MK, Chetelat G, Cross DJ, Djekidel M, Drzezga A, Ekmekcioglu O, Garibotto V, Hesse S, Ishii K, Jafari L, Lammertsma AA, Law I, Mathews D, Minoshima S, Mosci K, Pagani M, Pappata S, Silverman DH, Signore A, Van De Giessen E, Villemagne V, Barthel H; European Association of Nuclear Medicine (EANM) and of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). Morbelli S, et al. Among authors: garibotto v. Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):559-560. doi: 10.1007/s00259-016-3598-8. Eur J Nucl Med Mol Imaging. 2017. PMID: 27987029 No abstract available.
Hybrid PET-MRI in Alzheimer's Disease Research.
Mainta IC, Vargas MI, Trombella S, Frisoni GB, Unschuld PG, Garibotto V. Mainta IC, et al. Among authors: garibotto v. Methods Mol Biol. 2018;1750:185-200. doi: 10.1007/978-1-4939-7704-8_12. Methods Mol Biol. 2018. PMID: 29512073
279 results